Fexofozy Suspension contains Fexofenadine, a second-generation antihistamine widely used for the management of allergic rhinitis, chronic urticaria, and seasonal allergy symptoms. It provides effective relief from sneezing, itching, runny nose, and watery eyes.
Fexofenadine works by selectively blocking peripheral H1 receptors without crossing the blood-brain barrier, ensuring non-sedating, long-lasting allergy control suitable for daytime use.
The suspension formulation allows easy dosing and improved compliance, especially in pediatric and adolescent patients. Its strong safety profile makes it a preferred choice among physicians for long-term allergy management.
Adding Fexofozy Suspension to your anti-allergic and respiratory portfolio enhances your product range with a fast-moving, season-independent therapy. Its high prescription demand, pediatric suitability, and export readiness make it an excellent option for PCD pharma companies, distributors, and third-party manufacturing partners.